Orange Book product · Generic (ANDA)
FLUPHENAZINE HYDROCHLORIDE
FLUPHENAZINE HYDROCHLORIDE
At a glance
Oct 24, 2022
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Oct 24, 2022
3 yr 8 mo ago
Today
Pharmaceutical detail
Active ingredient
FLUPHENAZINE HYDROCHLORIDE
Strength
1MG
Dosage form
TABLET
Route
ORAL
TE code
AB
Application
ANDA 213784
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of FLUPHENAZINE HYDROCHLORIDE
- —PERMITILBrand (NDA)
NDA 016008 · SCHERING
- —PROLIXINBrand (NDA)
NDA 012145 · APOTHECON
- —PROLIXINBrand (NDA)
NDA 011751 · APOTHECON
- —PERMITILBrand (NDA)
NDA 012419 · SCHERING
- —PERMITILBrand (NDA)
NDA 012034 · SCHERING
- 2025FLUPHENAZINE HYDROCHLORIDEGeneric (ANDA)
ANDA 218769 · HETERO LABS LTD III
- 2024FLUPHENAZINE HYDROCHLORIDEGeneric (ANDA)
ANDA 218173 · ALEMBIC
- 2024FLUPHENAZINE HYDROCHLORIDEGeneric (ANDA)
ANDA 218283 · RISING
- 2024FLUPHENAZINE HYDROCHLORIDEGeneric (ANDA)
ANDA 217094 · TORRENT
- 2023FLUPHENAZINE HYDROCHLORIDEGeneric (ANDA)
ANDA 216350 · GLENMARK PHARMS LTD
- 2023FLUPHENAZINE HYDROCHLORIDEGeneric (ANDA)
ANDA 217189 · MSN
- 2023FLUPHENAZINE HYDROCHLORIDEGeneric (ANDA)
ANDA 218055 · AUROBINDO PHARMA LTD
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
